domperidone has been researched along with Body Weight in 15 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the role of spinal dopamine receptors in mediation of hypotension induced by systemic administration of the dopamine D2 receptor agonist, bromocriptine, conscious deoxycorticosterone acetate (DOCA)-salt hypertensive rats were pretreated with either intravenous (i." | 3.70 | Hypotensive action of bromocriptine in the DOCA-salt hypertensive rat: contribution of spinal dopamine receptors. ( Duarte, GP; Lahlou, S, 1998) |
| "1 mg of domperidone/kg of body weight/d; and 3." | 3.69 | Efficacy of domperidone and sulpiride as treatments for fescue toxicosis in horses. ( Cross, DL; Kennedy, SW; Redmond, LM; Strickland, JR, 1994) |
| " The circadian rhythm of beta-endorphin (beta-EP) and beta-lipotropin (beta-LPH), and their responses to the administration of corticotropin releasing hormone (CRH, 1 micrograms/kg body weight, i." | 3.68 | Peripheral opioid secretory pattern in anorexia nervosa. ( Brambilla, F; Catalano, M; Facchinetti, F; Ferrari, E; Genazzani, AR; Petraglia, F, 1991) |
| " A set of core outcomes to standardise infant weight and milk volume measurement is also needed, as well as a strong basis for the dose and dosage form used." | 2.66 | Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants. ( Foong, SC; Foong, WC; Ho, JJ; Marasco, LA; Ong, JH; Tan, ML, 2020) |
| "The pimozide-treated group showed high prolactin levels measured on day 23, at vaginal opening and at first oestrus." | 1.27 | Involvement of prolactin in the onset of puberty in female rats. ( Aguilar, E; Gonzalez, MD; López, F, 1984) |
| "Pretreatment with domperidone significantly facilitated recovery from lesion imposed deficits in consummatory behaviour and motor reflex control." | 1.27 | Peripheral DA receptor blockade facilitates behavioural recovery from nigrostriatal damage. ( Kinchington, PC; Smith, GC; Willis, GL, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Foong, SC | 1 |
| Tan, ML | 1 |
| Foong, WC | 1 |
| Marasco, LA | 1 |
| Ho, JJ | 1 |
| Ong, JH | 1 |
| Ameer, MW | 1 |
| Jabeen, F | 1 |
| Asad, M | 1 |
| Kaukab, G | 1 |
| Bashir, A | 1 |
| Rasheed, M | 1 |
| Younis, H | 1 |
| Munir, N | 1 |
| Nawaz, J | 1 |
| Zainab, R | 1 |
| Akram, M | 1 |
| Grzeskowiak, LE | 1 |
| Amir, LH | 1 |
| Smithers, LG | 1 |
| Julien, CA | 1 |
| Joseph, V | 1 |
| Bairam, A | 1 |
| Silva, EJ | 1 |
| Felicio, LF | 1 |
| Nasello, AG | 1 |
| Zaidan-Dagli, M | 1 |
| Anselmo-Franci, JA | 1 |
| Gonzalez, MD | 1 |
| López, F | 1 |
| Aguilar, E | 1 |
| Willis, GL | 1 |
| Smith, GC | 1 |
| Kinchington, PC | 1 |
| Tatsumi, K | 1 |
| Pickett, CK | 1 |
| Weil, JV | 1 |
| Kaya, F | 1 |
| Van Duin, CT | 1 |
| Van Miert, AS | 1 |
| Redmond, LM | 1 |
| Cross, DL | 1 |
| Strickland, JR | 1 |
| Kennedy, SW | 1 |
| Prasad, C | 1 |
| Ikegami, H | 1 |
| Shimizu, I | 1 |
| Onaivi, ES | 1 |
| Lahlou, S | 2 |
| Duarte, GP | 1 |
| Brambilla, F | 1 |
| Ferrari, E | 1 |
| Petraglia, F | 1 |
| Facchinetti, F | 1 |
| Catalano, M | 1 |
| Genazzani, AR | 1 |
| Sloley, BD | 1 |
| Trudeau, VL | 1 |
| Dulka, JG | 1 |
| Peter, RE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Placebo-Controlled Study of an Herbal Tea to Support Lactation[NCT02190448] | 60 participants (Actual) | Interventional | 2013-03-31 | Completed | |||
| Metoclopramide to Aid Establishment of Breastfeeding After Delivery: a Randomized Controlled Trial[NCT00264719] | 160 participants (Anticipated) | Interventional | 2006-01-31 | Completed | |||
| Assessing the Feasibility of Testing Domperidone's Effect on Breastfeeding in Women With Insufficient Breast Milk: An RCT Pilot Study[NCT00284024] | Phase 2 | 45 participants (Anticipated) | Interventional | 2006-09-30 | Terminated (stopped due to Unable to recruit participants) | ||
| Efficacy of Herbal Galactogogues on Weight Gain of the Newborns Within the First Month of Life in Breastfeeding Mothers[NCT02740751] | 90 participants (Anticipated) | Interventional | 2016-04-30 | Recruiting | |||
| Metoclopramide to Improve Lactogenesis II in Diabetic Women: a Randomized Controlled Trial[NCT00477776] | Phase 3 | 160 participants (Anticipated) | Interventional | 2006-04-30 | Completed | ||
| Effect of Fenugreek on Milk Production[NCT00851591] | 3 participants (Actual) | Interventional | 2008-09-30 | Terminated (stopped due to Low enrollment; investigator chose not to continue study) | |||
| Efficacy of Herbal Galactogogues: a Double-blinded, Placebo-controlled Randomized Trial.[NCT02233439] | 210 participants (Anticipated) | Interventional | 2014-09-30 | Not yet recruiting | |||
| Effect of Banana Blossom on Breast Milk Volume in Mothers of Preterm Newborns, a Randomized, Double Blinded, Placebo-controlled Trial[NCT05465460] | Phase 4 | 80 participants (Anticipated) | Interventional | 2022-07-09 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for domperidone and Body Weight
| Article | Year |
|---|---|
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
Topics: Administration, Oral; Body Weight; Breast Feeding; Domperidone; Female; Galactogogues; Humans; Infan | 2020 |
1 trial available for domperidone and Body Weight
| Article | Year |
|---|---|
Longer-term breastfeeding outcomes associated with domperidone use for lactation differs according to maternal weight.
Topics: Adult; Body Weight; Breast Feeding; Domperidone; Dopamine Antagonists; Female; Humans; Infant, Prema | 2018 |
13 other studies available for domperidone and Body Weight
| Article | Year |
|---|---|
Comparative efficacy of Ovaprim and hMG (menotropin) to induce breeding in African catfish (Clarias gariepinus).
Topics: Animals; Body Weight; Breeding; Catfishes; Domperidone; Drug Combinations; Female; Gonadotropin-Rele | 2021 |
Alteration of carotid body chemoreflexes after neonatal intermittent hypoxia and caffeine treatment in rat pups.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Apnea; Body Temperature; Body Weight; | 2011 |
Prolactin induces adrenal hypertrophy.
Topics: Adrenal Cortex; Animals; Body Weight; Domperidone; Hyperprolactinemia; Hypertrophy; Organ Size; Rats | 2004 |
Involvement of prolactin in the onset of puberty in female rats.
Topics: Adrenal Glands; Animals; Body Weight; Bromocriptine; Domperidone; Estrus; Female; Luteinizing Hormon | 1984 |
Peripheral DA receptor blockade facilitates behavioural recovery from nigrostriatal damage.
Topics: Animals; Behavior, Animal; Body Weight; Corpus Striatum; Domperidone; Drinking Behavior; Energy Inta | 1983 |
Possible role of dopamine in ventilatory acclimatization to high altitude.
Topics: Acclimatization; Altitude; Animals; Body Weight; Cats; Domperidone; Dopamine; Female; Hypercapnia; H | 1995 |
Effects of dopamine receptor agonists on food intake and rumen motility in dwarf goats.
Topics: Animals; Body Weight; Domperidone; Dopamine Agents; Dopamine Antagonists; Eating; Female; Gastrointe | 1994 |
Efficacy of domperidone and sulpiride as treatments for fescue toxicosis in horses.
Topics: Animal Feed; Animals; Animals, Newborn; Body Weight; Domperidone; Estradiol; Female; Foodborne Disea | 1994 |
Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons.
Topics: Aging; Animals; Apomorphine; Benzazepines; Binding Sites; Body Weight; Cellular Senescence; Corpus S | 1994 |
Hypotensive action of bromocriptine in the DOCA-salt hypertensive rat: contribution of spinal dopamine receptors.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Bromocriptine; Desoxycorticosterone; | 1998 |
Blunted pressor responsiveness to intravenous quinpirole in conscious, chronic spinal cord-transected rats: peripheral vs. spinal mechanisms.
Topics: Animals; Blood Pressure; Body Weight; Cordotomy; Domperidone; Dopamine Agonists; Dopamine Antagonist | 2000 |
Peripheral opioid secretory pattern in anorexia nervosa.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Anorexia Nervosa; beta-Endorphin; beta-Lipotropin; Body Weig | 1991 |
Selective depletion of dopamine in the goldfish pituitary caused by domperidone.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Benzazepi | 1991 |